리가켐바이오

141080KOSDAQ

41.9 / 100

Reference Date: 2026-09-08

Financial Score15.0 / 40

News Sentiment17.9 / 25

Momentum2.0 / 20

Disclosure7.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 18.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Ligacem Bio is a biopharmaceutical company specializing in next-generation ADC (Antibody-Drug Conjugate) technology through its proprietary platform 'ConjuALL', targeting unmet medical needs in oncology. The company has secured multiple technology transfer agreements with global pharmaceutical firms, including Fosun Pharma and Janssen, and reported revenue of approximately 10.54 billion KRW in 2024. It also operates a medical supply business, contributing to its diversified revenue streams.

Number of Employees

180people

Average Salary

157.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

6.31Industry Average 1.200.0Point

5.3x industry avg (risky)

ROE

-15.82Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

18.41Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲140.6% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼167.5% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -18.0% (improving, 3yr)

Detailed News Sentiment

19 totalPositive 11Neutral 4Negative 4Average Sentiment Score 71.6

Negative
올해 코스닥 상장 27개 그쳐…IPO 위축에 틀어막힌 VC 회수시장 [...
리가켐바이오를 포함한 코스닥 상장 기업 수가 감소하며 IPO 시장 위축으로 자금 회수가 어려워지고 있어 부정적 영향이 예상됩니다.
Neutral
코스닥 기술특례상장 300사 달성…누적 공모액 8조
기술특례상장 기업 증가로 코스닥 시장 활성화 추세 보이나, 리가켐바이오에 직접적 영향은 미미함.
Positive
리가켐·에이비엘바이오 “中에 수출한 ADC 후보물질, 1b상서 항암 효...
리가켐바이오와 에이비엘바이오의 ADC 후보물질이 중국 파트너 시스톤 파마슈티컬스를 통해 임상 시험에서 긍정적인 결과를 보여주며 기술 수출 성공.

Detailed Momentum

52-week position1.0Point

Near 52w low (10%, downtrend)

Current 92,300Won52-week high 213,50052-week low 77,900

1-month return0.0Point

1m -18.46% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 2Negative 1

Neutral대규모기업집단현황공시[분기별공시(개별회사용)]2026-08-31
Negative지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항2026-08-14
Neutral반기보고서 (2026.06)2026-08-14